NCT05440201 (ClotPara) is a NA clinical trial of Amount of anticoagulant Clexane in Bleeding, sponsored by University Hospital, Ghent.

Who is sponsoring NCT05440201?

NCT05440201 is sponsored by University Hospital, Ghent.

What drugs are being tested in NCT05440201?

Interventions in NCT05440201: Amount of anticoagulant Clexane.

What condition does NCT05440201 study?

NCT05440201 studies Bleeding, Coagulation.

Is NCT05440201 still recruiting?

NCT05440201 is currently completed. Last updated 30 May 2023.

Last reviewed 2023-05-30 · How we verify

NCT05440201: ClotPara

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Coupling Between Clotting Characteristics in Chronic Hemodialysis Patients and the Hemodialyzer Patency

Completed NA Last updated 30 May 2023

What this trial tests

NA trial testing Amount of anticoagulant Clexane in Bleeding in 20 participants. Completed in 20 May 2023.

Timeline

19 April 2023

Primary endpoint
20 May 2023

20 May 2023

Quick facts

Lead sponsor	University Hospital, Ghent
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	sequential
Masking	single
Primary purpose	treatment
Enrollment	20
Start date	19 April 2023
Primary completion	20 May 2023
Estimated completion	20 May 2023
Sites	1 location across Belgium

Drugs / interventions tested

Amount of anticoagulant Clexane

Conditions studied

Bleeding — all drugs for Bleeding →
Coagulation — all drugs for Coagulation →

Sponsor

University Hospital, Ghent

Who can join

18 and older, any sex, with Bleeding or Coagulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Twenty stable chronic hemodialysis patients are included and will undergo one, two, three or four midweek test dialysis sessions, depending on a flow chart to follow. All patients are started (week 1) with an anticoagulant Clexane 50IE/kg and are dialyzed with their regular dialyzer and dialysis machine. Depending on the results of measured clotting characteristics and of the dialyzer scanning (i.e. percentage open fibers), it is decided (via the flow chart) whether the patient gets a second session (and so on) with an adapted anticoagulation therapy to ameliorate fiber patency while limiting bleedings.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bleeding

Currently open trials in the same condition.

NCT07401394 — BAR-TAX - Tranexamic Acid in Bariatric Surgery. · NA · active not recruiting
NCT07309848 — Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs · recruiting
NCT07083583 — Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders · recruiting
NCT07019077 — Incidence of Late Haemorrhage After Invasive Gastroenterological Endoscopic Manoeuvre in Patients Treated With Anticoagu · recruiting
NCT07358416 — Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery. · active not recruiting

Other University Hospital, Ghent trials

Trials by the same sponsor.

NCT07584486 — Development of a New Simplified Tool to Predict LNPCPs Histology and Assess the Risk of Submucosal Invasive Cancer. The · NA · not yet recruiting
NCT07327450 — Coaching Doctors and Nurses to Improve Ethical Decision-making in Team · NA · not yet recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07387328 — Validation of New sEMG Electrode Placement Guidelines for the Triceps Surae in Post-stroke Individuals. · not yet recruiting
NCT07237399 — Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05440201 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Ghent
Last refreshed: 30 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05440201.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing